Fiford et al., 2020 - Google Patents
High blood pressure predicts hippocampal atrophy rate in cognitively impaired eldersFiford et al., 2020
View PDF- Document ID
- 12629251360027014741
- Author
- Fiford C
- Nicholas J
- Biessels G
- Lane C
- Cardoso M
- Barnes J
- Publication year
- Publication venue
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
External Links
Snippet
Introduction Understanding relationships among blood pressure (BP), cognition, and brain volume could inform Alzheimer's disease (AD) management. Methods We investigated Alzheimer's Disease Neuroimaging Initiative (ADNI) participants: 200 controls, 346 mild …
- 206010003694 Atrophy 0 title abstract description 38
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Biessels et al. | Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective | |
| Hoscheidt et al. | Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial | |
| Bangen et al. | Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults. | |
| Pegueroles et al. | Longitudinal brain structural changes in preclinical Alzheimer's disease | |
| Rafii et al. | The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome | |
| Ruitenberg et al. | Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study | |
| Vonk et al. | Semantic loss marks early Alzheimer's disease‐related neurodegeneration in older adults without dementia | |
| Fiford et al. | High blood pressure predicts hippocampal atrophy rate in cognitively impaired elders | |
| Van De Beek et al. | Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results | |
| Xiao et al. | White matter integrity and key structures affected in Alzheimer's disease characterized by diffusion tensor imaging | |
| Schmand et al. | Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts | |
| Hartley et al. | Role of tau deposition in early cognitive decline in Down syndrome | |
| Rao et al. | Disruption of response inhibition circuits in prodromal Huntington disease | |
| Palm et al. | Ventricular dilation: association with gait and cognition | |
| Alosco et al. | White matter hyperintensities in former American football players | |
| Ehlenbach et al. | Association between sepsis and microvascular brain injury | |
| Van Hooren et al. | Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study | |
| Kitaigorodsky et al. | The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults | |
| Holmqvist et al. | Longitudinal intraindividual cognitive variability is associated with reduction in regional cerebral blood flow among Alzheimer’s disease biomarker-positive older adults | |
| Lin et al. | Disrupted white matter functional connectivity in aMCI APOEε4 carriers: a resting-state study | |
| Pettigrew et al. | Computerized paired associate learning performance and imaging biomarkers in older adults without dementia | |
| Crane et al. | Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns | |
| Devanand et al. | Comparison of brief olfactory and cognitive assessments to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort | |
| Liu et al. | Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline | |
| Nagata et al. | Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease |